These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 15083744)

  • 21. Treatment of Adult Primary Alveolar Proteinosis.
    Rodríguez Portal JA
    Arch Bronconeumol; 2015 Jul; 51(7):344-9. PubMed ID: 25896950
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Autoimmune Pulmonary Alveolar Proteinosis Complicated with Sarcoidosis: the Clinical Course and Serum Levels of Anti-granulocyte-macrophage colony-stimulating Factor Autoantibody.
    Arai T; Kasai T; Shimizu K; Kawahara K; Katayama K; Sugimoto C; Hirose M; Okamoto H; Tachibana K; Akira M; Inoue Y
    Intern Med; 2020 Oct; 59(20):2539-2546. PubMed ID: 32611952
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [GM-CSF: a therapeutic alternative to the bronchoalveolar lavage in the treatment of alveolar proteinosis].
    Valdés L; Pose A; Alvarez D; Ventura M
    Med Clin (Barc); 2003 Feb; 120(3):117. PubMed ID: 12605734
    [No Abstract]   [Full Text] [Related]  

  • 24. Idiopathic pulmonary alveolar proteinosis as an autoimmune disease with neutralizing antibody against granulocyte/macrophage colony-stimulating factor.
    Kitamura T; Tanaka N; Watanabe J; Uchida ; Kanegasaki S; Yamada Y; Nakata K
    J Exp Med; 1999 Sep; 190(6):875-80. PubMed ID: 10499925
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A combination therapy of whole lung lavage and GM-CSF inhalation in pulmonary alveolar proteinosis.
    Yamamoto H; Yamaguchi E; Agata H; Kandatsu N; Komatsu T; Kawai S; Baba K; Awaya T; Nishikomori R; Tsurusawa M; Nakata K
    Pediatr Pulmonol; 2008 Aug; 43(8):828-30. PubMed ID: 18618617
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pulmonary alveolar proteinosis.
    Khan A; Agarwal R
    Respir Care; 2011 Jul; 56(7):1016-28. PubMed ID: 21496372
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [pulmonary alveolar proteinosis and anti-GM-CSF antibody].
    Watanabe M; Nakata K
    Nihon Naika Gakkai Zasshi; 2006 Jun; 95(6):1042-7. PubMed ID: 16846053
    [No Abstract]   [Full Text] [Related]  

  • 28. Pulmonary alveolar proteinosis in children: An unusual presentation with significant clinical impact.
    Iyengar JN; R Reddy BKK
    Indian J Pathol Microbiol; 2018; 61(3):418-420. PubMed ID: 30004070
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pulmonary alveolar proteinosis.
    Patel SM; Sekiguchi H; Reynolds JP; Krowka MJ
    Can Respir J; 2012; 19(4):243-5. PubMed ID: 22891182
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Pulmonary alveolar proteinosis: role of GM-CSF Antibodies].
    Ernst G; Salvado A; Grynblat P; Tabaj G; Garcia O; Cambursano VH; Young P
    Rev Fac Cien Med Univ Nac Cordoba; 2017; 74(1):46-50. PubMed ID: 28379131
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A plasmapheresis protocol for refractory pulmonary alveolar proteinosis.
    Garber B; Albores J; Wang T; Neville TH
    Lung; 2015 Apr; 193(2):209-11. PubMed ID: 25557091
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Autoimmune Pulmonary Alveolar Proteinosis: Evidence of the Pathogenicity of GM-CSF Antibodies.
    Le Gal A; Chabrol A; Brun AL; Fraboulet S; Couderc LJ; Salvator H
    Am J Respir Crit Care Med; 2021 Dec; 204(12):e134-e135. PubMed ID: 34129433
    [No Abstract]   [Full Text] [Related]  

  • 33. A newly identified novel variant in the CSF2RA gene in a child with pulmonary alveolar proteinosis: a case report.
    Al-Haidary AS; Alotaibi W; Alhaider SA; Al-Saleh S
    J Med Case Rep; 2017 May; 11(1):122. PubMed ID: 28464852
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Pulmonary alveolar proteinosis].
    Floarea-Strat A; Stanciu A; Creţeanu M
    Rev Med Chir Soc Med Nat Iasi; 2003; 107(3):518-23. PubMed ID: 14756054
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Will inhalational GM-CSF replace whole lung lavage as a treatment for autoimmune pulmonary alveolar proteinosis? Many pole positions, not yet the final winner.
    Bonella F; Manali ED; Papiris SA
    Eur Respir J; 2024 Jan; 63(1):. PubMed ID: 38176702
    [No Abstract]   [Full Text] [Related]  

  • 36. Cytokine profiles associated with disease severity and prognosis of autoimmune pulmonary alveolar proteinosis.
    Akasaka K; Amano M; Nakamura T; Nishizawa T; Yamakawa H; Sato S; Aoki A; Shima K; Matsushima H; Takada T
    Respir Investig; 2024 Jul; 62(4):610-616. PubMed ID: 38705133
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A mathematical model to predict protein wash out kinetics during whole-lung lavage in autoimmune pulmonary alveolar proteinosis.
    Akasaka K; Tanaka T; Maruyama T; Kitamura N; Hashimoto A; Ito Y; Watanabe H; Wakayama T; Arai T; Hayashi M; Moriyama H; Uchida K; Ohkouchi S; Tazawa R; Takada T; Yamaguchi E; Ichiwata T; Hirose M; Arai T; Inoue Y; Kobayashi H; Nakata K
    Am J Physiol Lung Cell Mol Physiol; 2015 Jan; 308(2):L105-17. PubMed ID: 25398988
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pulmonary alveolar proteinosis.
    Trapnell BC; Whitsett JA; Nakata K
    N Engl J Med; 2003 Dec; 349(26):2527-39. PubMed ID: 14695413
    [No Abstract]   [Full Text] [Related]  

  • 39. Whole-lung lavage in a patient with pulmonary alveolar proteinosis.
    Hunter Guevara LR; Gillespie SM; Klompas AM; Torres NE; Barbara DW
    Ann Card Anaesth; 2018; 21(2):215-217. PubMed ID: 29652291
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Pulmonary alveolar proteinosis: a disease caused by surfactant accumulation, and new treatment with sargramostim].
    Huisman P; Grutters JC; van den Bosch JM
    Ned Tijdschr Geneeskd; 2008 Jun; 152(26):1450-4. PubMed ID: 18666660
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.